, Tracking Stock Market Picks
Enter Symbol:
Rating: MED
up 6.00 %

Medifast Inc (NYSE: MED) downgraded to Neutral by Sidoti

Monday,  Nov 30, 2015  10:25 AM ET by Betsy O'Brien Harrison

Sidoti downgraded Medifast Inc (NYSE: MED) to Neutral. Previously Sidoti downgraded to Medifast Inc (NYSE: MED) to Buy on 10/05/2015,
when the stock price was $28.39. Since then, Medifast Inc's stock price has gained 6% as of 11/30/2015's recent price of $30.22.
If you would have followed the previous Sidoti's recommendation on MED, you would have gained 6% of your investment in 56 days.

Medifast, Inc. (Medifast) is engaged in the production, distribution, and sale of weight management and disease management products and other consumable health and diet products. The Company?s product lines include weight and disease management, meal replacement, and vitamins primarily manufactured in its modern, the United States Food and Drug Administration (FDA) approved facility in Owings Mills, Maryland. The Company?s operations are primarily conducted through five of its wholly owned subsidiaries, Jason Pharmaceuticals, Inc. (Jason), Take Shape for Life, Inc. (TSF), Jason Enterprises, Inc., Jason Properties, LLC and Seven Crondall, LLC. The Company offers a variety of weight and disease management products under the Medifast brand and for select private label customers. It's distribution channels include Medifast Direct, Take Shape for Life, Medifast Weight Control Centers and Medifast Physicians.


RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy